Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.9980
-0.0720 (-6.73%)
Jan 21, 2026, 3:46 PM CET
Neola Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 8.3 | 10.07 | 9.78 | 9.44 | 10.38 | 1.79 | Upgrade |
Other Revenue | 0.05 | 0.05 | 0.04 | 0.3 | 0.74 | 1.14 | Upgrade |
| 8.35 | 10.12 | 9.83 | 9.74 | 11.13 | 2.92 | Upgrade | |
Revenue Growth (YoY) | -24.36% | 2.97% | 0.84% | -12.43% | 280.64% | 3.65% | Upgrade |
Cost of Revenue | 0.4 | 1.37 | 1.77 | 1.42 | 1.33 | 0.25 | Upgrade |
Gross Profit | 7.95 | 8.75 | 8.06 | 8.32 | 9.8 | 2.67 | Upgrade |
Selling, General & Admin | 18.2 | 18.23 | 16.09 | 17.64 | 16.39 | 9.38 | Upgrade |
Other Operating Expenses | -0.3 | -0.21 | - | 0.03 | 0.04 | 0 | Upgrade |
Operating Expenses | 19.27 | 19.55 | 17.69 | 18.44 | 16.45 | 9.39 | Upgrade |
Operating Income | -11.32 | -10.8 | -9.63 | -10.12 | -6.65 | -6.72 | Upgrade |
Interest Expense | - | - | - | - | - | -0 | Upgrade |
Interest & Investment Income | 0.33 | 0.73 | 0.61 | 0.03 | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | -10.99 | -10.06 | -9.01 | -10.09 | -6.65 | -6.72 | Upgrade |
Asset Writedown | - | - | - | -0.27 | - | - | Upgrade |
Pretax Income | -10.99 | -10.06 | -9.01 | -10.35 | -6.65 | -6.72 | Upgrade |
Net Income | -10.99 | -10.06 | -9.01 | -10.35 | -6.65 | -6.72 | Upgrade |
Net Income to Common | -10.99 | -10.06 | -9.01 | -10.35 | -6.65 | -6.72 | Upgrade |
Shares Outstanding (Basic) | 75 | 70 | 56 | 26 | 14 | 9 | Upgrade |
Shares Outstanding (Diluted) | 75 | 70 | 56 | 26 | 14 | 9 | Upgrade |
Shares Change (YoY) | 12.14% | 25.80% | 113.90% | 86.03% | 48.67% | 34.66% | Upgrade |
EPS (Basic) | -0.15 | -0.14 | -0.16 | -0.40 | -0.47 | -0.71 | Upgrade |
EPS (Diluted) | -0.15 | -0.14 | -0.16 | -0.40 | -0.47 | -0.71 | Upgrade |
Free Cash Flow | -10.79 | -10.92 | -6.54 | -8.6 | -7.1 | -6.08 | Upgrade |
Free Cash Flow Per Share | -0.14 | -0.16 | -0.12 | -0.33 | -0.51 | -0.64 | Upgrade |
Gross Margin | 95.22% | 86.47% | 82.04% | 85.41% | 88.05% | 91.48% | Upgrade |
Operating Margin | -135.55% | -106.73% | -97.97% | -103.86% | -59.80% | -229.76% | Upgrade |
Profit Margin | -131.64% | -99.48% | -91.70% | -106.26% | -59.80% | -229.80% | Upgrade |
Free Cash Flow Margin | -129.26% | -107.90% | -66.59% | -88.27% | -63.83% | -207.83% | Upgrade |
EBITDA | -10.08 | -9.4 | -8.19 | -9.55 | -6.64 | -6.71 | Upgrade |
EBITDA Margin | -120.80% | -92.95% | -83.39% | -98.00% | -59.66% | -229.52% | Upgrade |
D&A For EBITDA | 1.23 | 1.39 | 1.43 | 0.57 | 0.02 | 0.01 | Upgrade |
EBIT | -11.32 | -10.8 | -9.63 | -10.12 | -6.65 | -6.72 | Upgrade |
EBIT Margin | -135.55% | -106.73% | -97.97% | -103.86% | -59.80% | -229.76% | Upgrade |
Revenue as Reported | - | - | - | 9.75 | 11.1 | 2.92 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.